Categories: News

Solo-Dex Facile(R) Peripheral Nerve Block Catheter Is Now Nationally Available

Evaluation Program Is Open to Qualified Hospitals and Surgical Centers

WOLF CREEK, MT / ACCESSWIRE / April 19, 2021 / Solo-Dex, a developer and distributor of medical catheters, announces the national availability of its Facile® continuous peripheral nerve block (cPNB catheter for managing pain before, during and after surgery. All Solo-Dex products are currently US FDA cleared and CE marked for Europe.

With Facile®, anesthesiologists can place and activate the facile continuous nerve block catheter quickly and safely for common procedures such as shoulder repair, hip and knee replacement as well as general surgical procedures. Facile leads the field in ease-of-use placement. The SOLO-DEX Fascile® simplifies and accelerates cPNB placement, improving patient comfort and post-procedure pain management. Patients report the need for opioids is drastically reduced and often eliminated altogether.

Regional anesthesia coupled with mild sedation may eliminate the need for a patient to receive general anesthesia which requires the manipulation of the airway. Manipulation of the airway increases the risk of Covid-19 exposure for the surgical team.

“Before the introduction of Solo-Dex Facile, the use of continuous regional anesthesia has been limited to a small group. Fascile has been developed specifically for the ease-of-use market which is up to 10 times larger than the current nerve catheter market,” says Steve Eror, CEO of Solo-Dex.

Regional anesthesia established and maintained by a small catheter offers safe and effective pain management for days before, during and after surgery. The patient tends to recover more quickly and may be released for home recovery with a block that eliminates the need for oral opioid painkillers.

According to the CDC, 40 people die from overdoses involving prescription opioids. The real cost of Opioid abuse is $1 Trillion from 2001-2017 according to the NY Times.

Interested physicians can obtain more information at www.solo-dex.com

ABOUT SOLO-DEX
Solo-Dex is a developer and distributor of medical catheter, founded by leading anesthesiologists to reduce the cost and risk associated with general anesthesia by improving surgical patient recovery times, reducing medical personnel exposure to covid-19, reducing or eliminating the misuse of opioid-related pain management, and by safely and effectively managing pain before, during and after a procedure. For more information about SOLO-DEX, please log on to www.solo-dex.com

Media Contact:
Janet Vasquez, Public Relations
Solo-Dex Inc.
pr@solo-dex.com

SOURCE: Solo-Dex, Inc.

View source version on accesswire.com:
https://www.accesswire.com/640748/Solo-Dex-FacileR-Peripheral-Nerve-Block-Catheter-Is-Now-Nationally-Available

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

11 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

14 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

14 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

14 hours ago